Hematide

Press Releases

All Releases |  2012 |  2011 |  2010

All Releases
Page: 1 2 3 4 5 6 7 8 9 10 11  Next
Feb 2, 2012 Affymax Promotes Cynthia Smith to Vice President, Market Access and Commercial Development PDF 8.1 KB Add to Briefcase
Jan 4, 2012 Affymax to Webcast Analyst Briefing Event PDF 8.0 KB Add to Briefcase
Dec 15, 2011 Takeda and Affymax Provide Update on Peginesatide Commercialization Rights in Japan PDF 12.8 KB Add to Briefcase
Dec 7, 2011 FDA Advisory Committee Voted in Favor of Benefit/Risk Profile for Peginesatide for Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis PDF 14.9 KB Add to Briefcase
Nov 11, 2011 Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology's Kidney Week 2011 PDF 74.0 KB Add to Briefcase
Nov 9, 2011 Affymax® Reports Third Quarter 2011 Financial Results PDF 16.3 KB Add to Briefcase
Nov 9, 2011 Affymax and Janssen Biotech Settle Patent Dispute PDF 9.8 KB Add to Briefcase
Oct 24, 2011 Affymax Announces FDA Advisory Committee to Review Peginesatide PDF 10.6 KB Add to Briefcase
Oct 10, 2011 Affymax and Takeda to Present Peginesatide Data at the American Society of Nephrology Kidney Week 2011 PDF 54.5 KB Add to Briefcase
Aug 31, 2011 Affymax Announces Upcoming Webcasts and Conference Participation PDF 42.5 KB Add to Briefcase
Aug 11, 2011 Affymax Announces Assignment of March 27, 2012 PDUFA Date for Peginesatide New Drug Application PDF 9.5 KB Add to Briefcase
Aug 10, 2011 Affymax® Receives $10 Million Milestone Payment for FDA Filing of New Drug Application for Hematide™/Peginesatide PDF 8.7 KB Add to Briefcase
Aug 8, 2011 Affymax® Reports Second Quarter 2011 Financial Results PDF 16.3 KB Add to Briefcase
Aug 3, 2011 Affymax Promotes Krishna R. Polu, M.D. to Vice President, Clinical Development PDF 7.5 KB Add to Briefcase
Jul 27, 2011 Affymax and Takeda Announce FDA Acceptance of New Drug Application for Peginesatide PDF 17.5 KB Add to Briefcase
May 31, 2011 Affymax and Takeda Announce the Submission of a New Drug Application for Peginesatide for the Treatment of Anemia Associated with Chronic Renal Failure in Patients on Dialysis PDF 18.0 KB Add to Briefcase
May 9, 2011 Affymax® Reports First Quarter 2011 Financial Results PDF 13.5 KB Add to Briefcase
Apr 28, 2011 Affymax and Takeda Report Additional Phase 3 Clinical Trial Data for Peginesatide in Dialysis Patients at the National Kidney Foundation Spring Clinical Meetings PDF 73.9 KB Add to Briefcase
Apr 27, 2011 Affymax Announces Upcoming Webcasts and Conference Participation PDF 6.2 KB Add to Briefcase
Apr 12, 2011 Affymax Names Andrew Blair, M.D., as Vice President of Medical Affairs PDF 6.7 KB Add to Briefcase
Showing 1-20 of 204 Page: 1 2 3 ... 11  Next